Aclarion, Inc. (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company, has been awarded a Diamond Pinnacle Award for AI Innovation in the Clinical Decision AI category, recognizing its Nociscan solution for chronic low back pain. This accolade follows the company's selection as a 2025 Digital Health Awards at HLTH winner, indicating growing external validation of Aclarion's mission to integrate objective biomarker analysis into clinical decision-making.
Chronic low back pain (cLBP) affects an estimated 266 million people worldwide and represents a significant healthcare burden. Aclarion's Nociscan platform leverages magnetic resonance spectroscopy (MRS) to identify chemical biomarkers in intervertebral discs. Proprietary algorithms classify whether a disc's biochemical profile is consistent with a painful or non-painful disc, providing physicians with objective data to optimize treatment planning. According to the company, clinical data demonstrates a 97% surgical success rate when all Nociscan-positive discs are treated.
Brent Ness, CEO of Aclarion, stated, "Receiving recognition from both the Pinnacle Awards and HLTH underscores the accelerating momentum behind our technology. Chronic low back pain remains one of the most challenging and costly conditions in medicine. Providing physicians with objective biochemical data has the potential to fundamentally improve how discogenic pain is evaluated and treated."
Nociscan is delivered through a cloud-based analytics platform, enabling rapid deployment across imaging centers and health systems without requiring new hardware infrastructure. This scalable model aligns with a new approach to MedTech innovation. The company continues to expand adoption among spine specialists seeking more objective diagnostic tools.
The Pinnacle Awards recognize outstanding achievement in AI innovation, and Aclarion's win in the Clinical Decision AI category underscores the impact of its technology. For more information about Aclarion and Nociscan, visit www.aclarion.com and the company's newsroom at https://tinyurl.com/aconnewsroom.
